Review the side-effects of Triptorelin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

(HealthDay News) — For female patients with childhood-onset systemic lupus erythematosus (SLE) who require treatment with cyclophosphamide, sustained complete ovarian suppression is achieved in 90% of ...

Elderly patients with metastatic castrate-resistant prostate cancer (mCRPC): Safety and efficacy of docetaxel retreatment. Background: Medical castration using gonadotropin-releasing hormone (GnRH) ...

Women with polycystic ovary syndrome have less increase in follicle-stimulating hormone after triptorelin administration during in vitro fertilization than women without PCOS, according to data from ...

Del Mastro L, Boni L, Michelotti A, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with ...

March 15, 2010 — The US Food and Drug Administration (FDA) has approved a twice-yearly 22.5-mg formulation of triptorelin pamoate injection (Trelstar, Watson Pharmaceuticals, Inc) for the palliative ...

Nodal Stage Classification for Breast Carcinoma: Improving Interobserver Reproducibility Through Standardized Histologic Criteria and Image-Based Training Prospectively collected hormonal data were ...

Details concerning the Triptorelin Pamoate for Injectable Suspension medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ...

Chemotherapy for breast cancer in premenopausal women causes menopause (premature ovarian failure) in a variable proportion of patients, ranging from 0% to 90% depending on the treatment received and ...

Gonadotropin-releasing hormone (GnRH) agonists are more effective and safe compared to estrogens and anti-androgens used to attain medical castration. GnRH agonists offer slow-release formulations ...